ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Novo Nordisk

Novo Nordisk (NOV)

85.56
3.80
(4.65%)
Closed December 25 4:00PM
Realtime Data

Novo Nordisk Financial Summary

The current NOV market cap is 384.68B. The company's latest EPS is DKK 18.6127 and P/E is 4.65.

Year End December 30 2023 20192020202120222023
DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
Total Revenue 122.02B126.95B140.8B176.95B232.26B
Operating Income 52.35B54.28B58.62B74.62B102.66B
Net Income 38.95B42.14B47.76B55.53B83.68B
Year End December 30 2023 20192020202120222023
DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
Total Assets 125.61B144.92B194.51B241.26B314.49B
Total Liabilities 68.02B81.6B123.76B157.77B207.93B
Total Equity 57.59B63.33B70.75B83.49B106.56B

Cash Flow

Year End December 30 2023 20192020202120222023
DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
Operating 46.78B51.95B55B78.89B108.91B
Investing -11.51B-22.44B-31.61B-24.92B-43.89B
Financing -35.48B-32.24B-25.49B-51.8B-63.16B
Market Cap 384.68B
Price to Earnings Ratio 4.65
Price to Sales Ratio 1.68
Price to Cash Ratio 27.06
Price to Book Ratio 3.65
Dividend Yield 86.32%

Share Statistics

Shares Outstanding 4.5B
Average Volume (1 week) 246.1k
Average Volume (1 Month) 111.42k
52 Week Change -8.10%
52 Week High 139.88
52 Week Low 71.01
Spread (Intraday) 0.27 (0.32%)

Company Info

Company Name Novo Nordisk
Address novo alle
bagsvaerd DK-2880
Website https://www.novonordisk.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock